Our Website Uses Cookies 

We and the third parties that provide content, functionality, or business services on our website may use cookies to collect information about your browsing activities in order to provide you with more relevant content and promotional materials, on and off the website, and help us understand your interests and improve the website.

For more information, please contact us or consult our Privacy Notice.

Your binder contains too many pages, the maximum is 40.

We are unable to add this page to your binder, please try again later.

This page has been added to your binder.

Julie Plyler is a member of the firm’s corporate practice group and focuses on capital markets and securities transactions in the life sciences industry. She also represents companies in connection with financing transactions.

  • Banca Intesa Sanpaolo on U.S. law aspects of its tender offer for, and subsequent acquisition of, UBI Banca.
  • REGENXBIO Inc. in a $230.3 million public offering of common stock.
  • Omeros Corporation in a $210 million convertible notes offering and $100 million common stock offering.
  • Insmed Incorporated in a $259.3 million public offering of common stock.
  • TriState Capital Holdings in various capital markets offerings, including $121 million of depositary share offerings, $97.5 million of subordinated debt offerings and a $105 million private placement.
  • The underwriters in the initial public offerings of Trevi Therapeutics, Inc. and Nightstar Therapeutics plc.
  • The underwriters in a global offering of ordinary shares and ADSs of ERYTECH Pharma S.A.
  • The underwriters in various follow-on offerings, including those of UroGen Pharma Ltd., Corbus Pharmaceuticals Holdings, Inc., RedHill BioPharma Ltd. and Nabriva Therapeutics plc.
  • The sales agent in various at-the-market offerings, including those of Corbus Pharmaceuticals Holdings, Inc., Celldex Therapeutics, Inc. and Nabriva Therapeutics plc.
  • Johnson & Johnson in its sale of RoC Skincare.
  • SK Holdings in its acquisition of a significant minority interest in Eureka Midstream.
  • Advises public companies on Exchange Act periodic reporting, proxy statements, Section 16 reporting and securities compliance matters.

Pro Bono

  • Provides legal services and advice to the Jackie Robinson Foundation, a national, not-for-profit organization committed to perpetuating the memory of Jackie Robinson by promoting civic engagement and humanitarian ideals as well as addressing the achievement gap in higher education, in connection with the development of the Jackie Robinson Museum.